Fig. 3From: Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?Estimated power by the four different VE methods by mean number of clones transferred per exposure (Panel A) and mean VE estimator values across simulations (Panel B) with variability represented by 2.5th and 97.5th percentiles. VE methods were calculated for the same sample sizes; the displayed intervals are staggered to distinguish them visuallyBack to article page